Sign in

CIK 0001737953

  • Non-accelerated filer
  • Smaller reporting company

Replimune Group, Inc.

Sign in to watch
Ticker
REPL
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Mar 31
Incorporated
DE
Entity type
Operating
EIN
822082553
Phone
+1 781-222-9600
Business address
500 UNICORN PARK, WOBURN, MA, 01801
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$521,860
in 2 filings

Net −$521,860. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Dhingra Kapil −$409K Director sold 50% of stake
  2. SLATTERY JOSEPH P −$113K Director sold 78% of stake

Reading 83 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2021-04-01 Slootweg Hugo Alexander Director Grant or award · Stock Option (right to buy) +16,500 16,500
2021-04-01 SLATTERY JOSEPH P Director Grant or award · Stock Option (right to buy) +16,500 16,500
2021-04-01 Dhingra Kapil Director Grant or award · Stock Option (right to buy) +16,500 16,500
2021-04-01 Omega Fund IV, L.P. Director Grant or award · Stock Option (Right to Buy) +16,500 16,500
2021-03-15 Love Colin Chief Operating Officer Sale −11,382 $34.06 $388K 905,142
2021-03-15 Love Colin Chief Operating Officer Sale −18,518 $33.22 $615K 886,624
2021-03-15 Love Colin Chief Operating Officer Sale −100 $32.67 $3K 886,524
2021-02-16 Love Colin Chief Operating Officer Sale −18,620 $36.61 $682K 927,904
2021-02-16 Love Colin Chief Operating Officer Sale −11,380 $35.84 $408K 916,524
2021-02-08 Omega Fund IV, L.P. 10% owner Sale −5,249 $45.00 $236K 5,141,321
2021-01-26 Rhodes Jason P Director Sale −5,558 $46.14 $256K 946,000
2021-01-26 Omega Fund IV, L.P. Director Sale −26,957 $45.34 $1.2M 5,287,075
2021-01-26 Omega Fund IV, L.P. Director Sale −3,393 $46.04 $156K 5,283,682
2021-01-22 Coffin Robert President & Chief R&D Officer Sale −30,197 $44.87 $1.4M 1,773,921
2021-01-22 Coffin Robert President & Chief R&D Officer Sale −29,803 $43.99 $1.3M 1,744,118
2021-01-22 Omega Fund IV, L.P. Director Sale −8,090 $45.05 $364K 5,317,301
2021-01-22 Omega Fund IV, L.P. Director Sale −3,269 $45.03 $147K 5,314,032
2021-01-19 Esposito Pamela Chief Business Officer Option exercise +5,727 $1.01 $6K 181,721
2021-01-19 Esposito Pamela Chief Business Officer Sale −600 $43.24 $26K 181,121
2021-01-19 Esposito Pamela Chief Business Officer Sale −5,127 $42.38 $217K 175,994

Page 15 of 19 · 365 trades